Research and development (including 1,137 and 613 for the three months ended june 30, 2026 and 2025, respectively, from a related party and 2,845 and 821 for the six months ended june 30, 2026 and 2025, respectively, from a related party)
39,129,000
35,680,000
31,623,000*
27,252,000
General and administrative
12,765,000
13,439,000
18,960,000*
16,070,000
Restructuring and impairment
578,000
796,000
8,450,500*
140,000
Gain on sale of the huntsville manufacturing facility
-
-
0*
-
Total operating costs and expenses
52,472,000
49,915,000
59,033,500*
43,462,000
Loss from operations
-42,341,000
-39,054,000
-38,249,000*
-31,672,000
Non-cash interest expense on liabilities related to the sales of future royalties
7,206,000
7,942,000
9,022,500*
6,047,000
Interest income
9,346,000
4,242,000
3,256,000*
2,819,000
Other income (expense), net (including income of 0 and 540 for the three months ended june 30, 2026 and 2025, respectively, from a related party and income of 2 and 861 for the six months ended june 30, 2026 and 2025, respectively, from a related party)
-100,000
-336,000
152,500*
-121,000
Total non-operating income (expense), net
2,040,000
-4,036,000
-5,614,000*
-3,349,000
Loss before provision (benefit) for income taxes and equity method investment
-40,301,000
-43,090,000
-43,863,000*
-35,021,000
Provision (benefit) for income taxes
2,000
64,000
193,500*
-33,000
Loss before equity method investment
-40,303,000
-43,154,000
-44,056,500*
-34,988,000
Loss from equity method investment
-319,000
-1,750,000
-4,347,000*
-534,000
Net loss
-40,622,000
-44,904,000
-48,403,500
-35,522,000
Basic EPS
-1.23
-1.82
-2.753
-1.87
Diluted EPS
-1.23
-1.82
-2.753
-1.87
Basic Average Shares
33,054,865
24,736,066
17,578,924
18,946,559
Diluted Average Shares
33,054,865
24,736,066
17,578,924
18,946,559
Unit: Dollar. Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.